Sun Pharmaceutical Industries Limited (SUNPHARMA NSE) stock market data APIs
INR1694.0349
21.51(1.3%)
as of October 31, 2025
Try our APIs with
free plan!
Sun Pharmaceutical Industries Limited Financial Data Overview
Price chart is built with
Anychart
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
Prev. Close
1694.0349
Open
1715.5453
High
1711.296
Low
1682.2113
52 wk Range
1547.9647-1892.3413
Market Cap
4 056 555 M
P/E Ratio
39.0733
Shares Outstanding
2 399 M
Revenue
537 771 M
Dividends (Yield)
0
Beta
0.282
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sun Pharmaceutical Industries Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sun Pharmaceutical Industries Limited data using free add-ons & libraries
Get Sun Pharmaceutical Industries Limited Fundamental Data
Sun Pharmaceutical Industries Limited Fundamental data includes:
- Net Revenue: 537 771 M
- EBITDA: 153 387 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 11.97
Get Sun Pharmaceutical Industries Limited End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sun Pharmaceutical Industries Limited News
New
India's Gland Pharma posts quarterly profit rise on Cenexi recovery, Europe sales growth
(Reuters) -India's Gland Pharma reported a nearly 50% jump in first-quarter profit on Tuesday, driven by better margins and a recovery at its European unit Cenexi. The company reported a consolidated...
India's Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
By Rishika Sadam (Reuters) -India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the settlement of a patent dispute with Incyte Corp. ...
Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer
Shares of Concert Pharmaceuticals, Inc. CNCE were up 17.4% last week on its proposed acquisition by India-based Sun Pharmaceutical Industries Ltd. On Jan 19, Concert Pharmaceuticals announced a defini...
5 big deal reports: Sun Pharma’s $576M pact for Concert Pharma
By Davit Kirakosyan Investing.com -- Among the biggest deal dispatches this past week, Sun Pharmaceutical said it would take out Concert Pharma, and Microsoft’s bid to acquire Activision may face a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
